|
1
|
Brigstock DR: The connective tissue growth
factor/cysteine-rich 61/nephroblastoma overexpressed. Endocr Rev.
20:189–206. 1999.PubMed/NCBI
|
|
2
|
Dhar A and Ray A: The CCN family proteins
in carcinogenesis. Exp Oncol. 32:2–9. 2010.PubMed/NCBI
|
|
3
|
Shimo T, Nakanishi T, Nishida T, et al:
Connective tissue growth factor induces the proliferation,
migration, and tube formation of vascular endothelial cells in
vitro, and angiogenesis in vivo. J Biochem. 126:137–145. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jacobson A and Cunningham JL: Connective
tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue
Repair. 5(Suppl 1): S82012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YQ, Sloan-Lancaster J, Berg DT, et
al: Differential mechanisms of plasminogen activator inhibitor-1
gene activation by transforming growth factor-beta and tumor
necrosis factor-alpha in endothelial cells. Thromb Haemost.
86:1563–1572. 2001.
|
|
6
|
Robinson PM, Smith TS, Patel D, et al:
Proteolytic processing of connective tissue growth factor in normal
ocular tissues and during corneal wound healing. Invest Ophthalmol
Vis Sci. 53:8093–8103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brigstock DR: Regulation of angiogenesis
and endothelial cell function by connective tissue growth factor
(CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 5:153–165. 2002.
View Article : Google Scholar
|
|
8
|
Moussad EE and Brigstock DR: Connective
tissue growth factor: what’s in a name? Mol Genet Metab.
71:276–292. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Granel B, Argiro L, Hachulla E, et al:
Association between a CTGF gene polymorphism and systemic sclerosis
in a French population. J Rheumatol. 37:351–358. 2010. View Article : Google Scholar
|
|
10
|
Wang X, Wan F, Pan J, et al: Tumor size: a
non-neglectable independent prognostic factor for gastric cancer. J
Surg Oncol. 97:236–240. 2008. View Article : Google Scholar
|
|
11
|
Wang B, Carter RE, Jaffa MA, et al;
DCCT/EDIC Study Group. Genetic variant in the promoter of
connective tissue growth factor gene confers susceptibility to
nephropathy in type 1 diabetes. J Med Genet. 47:391–397. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dessein A, Chevillard C, Arnaud V, et al:
Variants of CTGF are associated with hepatic fibrosis in Chinese,
Sudanese, and Brazilians infected with schistosomes. J Exp Med.
206:2321–2328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koliopanos A, Friess H, di Mola FF, et al:
Connective tissue growth factor gene expression alters tumor
progression in esophageal cancer. World J Surg. 26:420–427. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou ZQ, Cao WH, Xie JJ, et al: Expression
and prognostic significance of THBS1, Cyr61 and CTGF in esophageal
squamous cell carcinoma. BMC Cancer. 9:2912009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Li Z, Feng G, You W and Li J:
Expression of connective tissue growth factor is in agreement with
the expression of VEGF, VEGF-C, -D and associated with shorter
survival in gastric cancer. Pathol Int. 57:712–718. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen PP, Li WJ, Wang Y, et al: Expression
of Cyr61, CTGF, and WISP-1 correlates with clinical features of
lung cancer. PLoS One. 2:e5342007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chien W, O’Kelly J, Lu D, et al:
Expression of connective tissue growth factor (CTGF/CCN2) in breast
cancer cells is associated with increased migration and
angiogenesis. Int J Oncol. 38:1741–1747. 2011.PubMed/NCBI
|
|
18
|
Zhen Y, Ye Y, Yu X, et al: Reduced CTGF
expression promotes cell growth, migration, and invasion in
nasopharyngeal carcinoma. PLoS One. 8:e649762013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ladwa R, Pringle H, Kumar R and West K:
Expression of CTGF and Cyr61 in colorectal cancer. J Clin Pathol.
64:58–64. 2011. View Article : Google Scholar
|
|
20
|
Lin BR, Chang CC, Chen RJ, et al:
Connective tissue growth factor acts as a therapeutic agent and
predictor for peritoneal carcinomatosis of colorectal cancer. Clin
Cancer Res. 17:3077–3088. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bidwell J, Keen L, Gallagher G, et al:
Cytokine gene polymorphism in human disease: on-line databases.
Genes Immun. 1:3–19. 1999. View Article : Google Scholar
|
|
22
|
Pivovarova O, Fisher E, Dudziak K, et al:
A polymorphism within the connective tissue growth factor (CTGF)
gene has no effect on non-invasive markers of beta-cell area and
risk of type 2 diabetes. Dis Markers. 31:241–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poli F, Boschiero L, Giannoni F, et al:
Tumour necrosis factor-alpha gene polymorphism: implications in
kidney transplantation. Cytokine. 12:1778–1783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Awad MR, El-Gamel A, Hasleton P, et al:
Genotypic variation in the transforming growth factor-beta1 gene:
association with transforming growth factor-beta1 production,
fibrotic lung disease, and graft fibrosis after lung
transplantation. Transplantation. 66:1014–1020. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bylund JR, Gayheart D, Fleming T, et al:
Association of tumor size, location, R.E.N.A.L., PADUA and
centrality index score with perioperative outcomes and
postoperative renal function. J Urol. 188:1684–1689. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Compton CC: Colorectal carcinoma:
diagnostic, prognostic, and molecular features. Mod Pathol.
16:376–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung CK, Kang YG, Bae JS, et al: Unique
patterns of tumor growth related with the risk of lymph node
metastasis in papillary thyroid carcinoma. Mod Pathol.
23:1201–1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jass JR: The pathological classification
of colorectal cancer. Ann Acad Med Singapore. 16:469–473.
1987.PubMed/NCBI
|
|
29
|
Jass JR, Atkin WS, Cuzick J, et al: The
grading of rectal cancer: historical perspectives and a
multivariate analysis of 447 cases. Histopathology. 41:59–81.
2002.PubMed/NCBI
|
|
30
|
Franzén LE, Hahn-Strömberg V, Edvardsson H
and Bodin L: Characterization of colon carcinoma growth pattern by
computerized morphometry: definition of a complexity index. Int J
Mol Med. 22:465–472. 2008.PubMed/NCBI
|
|
31
|
Ohene-Abuakwa Y and Pignatelli M: Adhesion
molecules as diagnostic tools in tumor pathology. Int J Surg
Pathol. 8:191–200. 2000. View Article : Google Scholar
|
|
32
|
Lee HK, Bier A, Cazacu S, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mannan A and Hahn-Strömberg V: K-ras
mutations are correlated to lymph node metastasis and tumor stage,
but not to the growth pattern of colon carcinoma. APMIS.
120:459–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hahn-Strömberg V, Edvardsson H, Bodin L
and Franzén L: Tumor volume of colon carcinoma is related to the
invasive pattern but not to the expression of cell adhesion
proteins. APMIS. 117:205–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao YB, Xiang ZL, Zhou LY, et al: Enhanced
production of CTGF and IL-11 from highly metastatic hepatoma cells
under hypoxic conditions: an implication of hepatocellular
carcinoma metastasis to bone. J Cancer Res Clin Oncol. 139:669–679.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: miR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Heinzle C, Gsur A, Hunjadi M, et al:
Differential effects of polymorphic alleles of FGF receptor 4 on
colon cancer growth and metastasis. Cancer Res. 72:5767–5777. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhong R, Liu L, Zou L, et al: Genetic
variations in the TGFβ signaling pathway, smoking and risk of
colorectal cancer in a Chinese population. Carcinogenesis.
34:936–942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jang MJ, Jeon YJ, Kim JW, et al:
Association of VEGF and KDR single nucleotide polymorphisms with
colorectal cancer susceptibility in Koreans. Mol Carcinog. 52(Suppl
1): E60–69. 2013. View Article : Google Scholar
|
|
40
|
Hahn-Strömberg V, Edvardsson H, Bodin L
and Franzén L: Disturbed expression of E-cadherin, beta-catenin and
tight junction proteins in colon carcinoma is unrelated to growth
pattern and genetic polymorphisms. APMIS. 116:253–262. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fonseca C, Lindahl GE, Ponticos M, et al:
A polymorphism in the CTGF promoter region associated with systemic
sclerosis. N Engl J Med. 357:1210–1220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Greenawalt DM, Sieberts SK, Cornelis MC,
et al: Integrating genetic association, genetics of gene
expression, and single nucleotide polymorphism set analysis to
identify susceptibility Loci for type 2 diabetes mellitus. Am J
Epidemiol. 176:423–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Katakami N, Kume S, Kaneto H, et al:
Association of myeloperoxidase G-463A gene polymorphism with
diabetic nephropathy. Endocr J. 60:457–471. 2012.
|
|
44
|
Guo H, Bao Z, Li J, et al: Molecular
characterization of TGF-β type I receptor gene (Tgfbr1) in Chlamys
farreri, and the association of allelic variants with growth
traits. PLoS One. 7:e510052012. View Article : Google Scholar
|
|
45
|
Kovalenko E, Tacke F, Gressner OA, et al:
Validation of connective tissue growth factor (CTGF/CCN2) and its
gene polymorphisms as noninvasive biomarkers for the assessment of
liver fibrosis. J Viral Hepat. 16:612–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Davies SR, Davies ML, Sanders A, et al:
Differential expression of the CCN family member WISP-1, WISP-2 and
WISP-3 in human colorectal cancer and the prognostic implications.
Int J Oncol. 36:1129–1136. 2010.PubMed/NCBI
|
|
47
|
Lin BR, Chang CC, Che TF, et al:
Connective tissue growth factor inhibits metastasis and acts as an
independent prognostic marker in colorectal cancer.
Gastroenterology. 128:9–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chang CC, Lin MT, Lin BR, et al: Effect of
connective tissue growth factor on hypoxia-inducible factor 1alpha
degradation and tumor angiogenesis. J Natl Cancer Inst. 98:984–995.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Deng YZ, Chen PP, Wang Y, et al:
Connective tissue growth factor is overexpressed in esophageal
squamous cell carcinoma and promotes tumorigenicity through
beta-catenin-T-cell factor/Lef signaling. J Biol Chem.
282:36571–36581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Victoria HS, Henrik E, Lennart B and
Lennart F: Claudin 1 and claudin 7 gene polymorphisms and protein
derangement are unrelated to the growth pattern and tumor volume of
colon carcinoma. Int J Biomed Sci. 6:96–102. 2010.PubMed/NCBI
|
|
51
|
Margadant C and Sonnenberg A:
Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing.
EMBO Rep. 11:97–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Radisky DC, Kenny PA and Bissell MJ:
Fibrosis and cancer: do myofibroblasts come also from epithelial
cells via EMT? J Cell Biochem. 101:830–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
